

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microglial cell activation (GO:0001774) | 5.41165971 |
| 2 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.32864744 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.11760650 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 4.79555369 |
| 5 | positive regulation of chemokine secretion (GO:0090197) | 4.39605623 |
| 6 | lymph vessel development (GO:0001945) | 4.25498542 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.25219804 |
| 8 | regulation of chemokine secretion (GO:0090196) | 4.19211707 |
| 9 | macrophage activation (GO:0042116) | 4.02410793 |
| 10 | negative regulation of complement activation (GO:0045916) | 3.97680697 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.84956935 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.79728205 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.79728205 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.79728205 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.79728205 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.79728205 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.79728205 |
| 18 | keratan sulfate catabolic process (GO:0042340) | 3.74725599 |
| 19 | basement membrane organization (GO:0071711) | 3.68170121 |
| 20 | adhesion of symbiont to host (GO:0044406) | 3.63961577 |
| 21 | oligosaccharide catabolic process (GO:0009313) | 3.58701871 |
| 22 | negative regulation of protein activation cascade (GO:2000258) | 3.58348055 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.55211202 |
| 24 | cellular extravasation (GO:0045123) | 3.48837338 |
| 25 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.44836225 |
| 26 | endothelial cell morphogenesis (GO:0001886) | 3.42267959 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40619995 |
| 28 | positive regulation of p38MAPK cascade (GO:1900745) | 3.37877516 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.32259374 |
| 30 | melanin biosynthetic process (GO:0042438) | 3.30912532 |
| 31 | positive regulation of odontogenesis (GO:0042482) | 3.30146814 |
| 32 | response to peptidoglycan (GO:0032494) | 3.29976168 |
| 33 | negative regulation of humoral immune response (GO:0002921) | 3.27453663 |
| 34 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.23689899 |
| 35 | transcytosis (GO:0045056) | 3.22579890 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.20620301 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.20524969 |
| 38 | apoptotic cell clearance (GO:0043277) | 3.20429339 |
| 39 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.19494907 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 3.19371756 |
| 41 | response to thyroid hormone (GO:0097066) | 3.14819851 |
| 42 | response to laminar fluid shear stress (GO:0034616) | 3.12952617 |
| 43 | cellular response to epinephrine stimulus (GO:0071872) | 3.10655829 |
| 44 | endothelium development (GO:0003158) | 3.09067895 |
| 45 | regulation of endothelial cell differentiation (GO:0045601) | 3.08424401 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.06009883 |
| 47 | glycolipid catabolic process (GO:0019377) | 3.04884671 |
| 48 | wound healing, spreading of epidermal cells (GO:0035313) | 3.01020072 |
| 49 | iron ion import (GO:0097286) | 3.00393329 |
| 50 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99628317 |
| 51 | glomerular visceral epithelial cell development (GO:0072015) | 2.98748856 |
| 52 | regulation of interferon-alpha production (GO:0032647) | 2.96974468 |
| 53 | melanin metabolic process (GO:0006582) | 2.96040303 |
| 54 | lymphangiogenesis (GO:0001946) | 2.92198121 |
| 55 | cell adhesion mediated by integrin (GO:0033627) | 2.91919276 |
| 56 | ovulation from ovarian follicle (GO:0001542) | 2.88975949 |
| 57 | response to epinephrine (GO:0071871) | 2.88917456 |
| 58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.87386822 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 2.87348006 |
| 60 | adenosine receptor signaling pathway (GO:0001973) | 2.86972208 |
| 61 | phenylpropanoid metabolic process (GO:0009698) | 2.83384354 |
| 62 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.83351672 |
| 63 | positive regulation of astrocyte differentiation (GO:0048711) | 2.82497937 |
| 64 | detection of external biotic stimulus (GO:0098581) | 2.82452056 |
| 65 | protein localization to endosome (GO:0036010) | 2.82332674 |
| 66 | establishment of endothelial barrier (GO:0061028) | 2.82308285 |
| 67 | regulation of mononuclear cell migration (GO:0071675) | 2.80529485 |
| 68 | pinocytosis (GO:0006907) | 2.80083544 |
| 69 | virion attachment to host cell (GO:0019062) | 2.79518025 |
| 70 | adhesion of symbiont to host cell (GO:0044650) | 2.79518025 |
| 71 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78898423 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 2.78065688 |
| 73 | I-kappaB phosphorylation (GO:0007252) | 2.76783267 |
| 74 | phagocytosis, recognition (GO:0006910) | 2.75171473 |
| 75 | macrophage chemotaxis (GO:0048246) | 2.74778990 |
| 76 | histamine secretion (GO:0001821) | 2.72192712 |
| 77 | mannose metabolic process (GO:0006013) | 2.71912094 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.71246273 |
| 79 | embryonic process involved in female pregnancy (GO:0060136) | 2.69990628 |
| 80 | peptide catabolic process (GO:0043171) | 2.67426430 |
| 81 | cGMP-mediated signaling (GO:0019934) | 2.67278267 |
| 82 | detection of other organism (GO:0098543) | 2.66898913 |
| 83 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.66259261 |
| 84 | ceramide catabolic process (GO:0046514) | 2.64630202 |
| 85 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.63684518 |
| 86 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.63471730 |
| 87 | regulation of p38MAPK cascade (GO:1900744) | 2.63252745 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.62380279 |
| 89 | cyclooxygenase pathway (GO:0019371) | 2.62099174 |
| 90 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.60566566 |
| 91 | cellular response to interleukin-6 (GO:0071354) | 2.59370938 |
| 92 | phagocytosis, engulfment (GO:0006911) | 2.57676175 |
| 93 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56880688 |
| 94 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.56630909 |
| 95 | detection of biotic stimulus (GO:0009595) | 2.56340092 |
| 96 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.56243059 |
| 97 | amino sugar catabolic process (GO:0046348) | 2.56178944 |
| 98 | renal filtration (GO:0097205) | 2.55424386 |
| 99 | regulation of vitamin metabolic process (GO:0030656) | 2.54855669 |
| 100 | cellular response to ethanol (GO:0071361) | 2.54448761 |
| 101 | response to fluid shear stress (GO:0034405) | 2.54063481 |
| 102 | angiotensin maturation (GO:0002003) | 2.53809946 |
| 103 | protein kinase C signaling (GO:0070528) | 2.53282206 |
| 104 | purinergic receptor signaling pathway (GO:0035587) | 2.52536321 |
| 105 | positive regulation of receptor recycling (GO:0001921) | 2.52233403 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 2.51146454 |
| 107 | regulation of macrophage chemotaxis (GO:0010758) | 2.50738075 |
| 108 | secondary metabolite biosynthetic process (GO:0044550) | 2.50350223 |
| 109 | regulation of monocyte chemotaxis (GO:0090025) | 2.50043435 |
| 110 | glomerular epithelial cell development (GO:0072310) | 2.49981246 |
| 111 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.49252267 |
| 112 | membrane lipid catabolic process (GO:0046466) | 2.48425119 |
| 113 | negative regulation of interleukin-6 production (GO:0032715) | 2.47647680 |
| 114 | response to muramyl dipeptide (GO:0032495) | 2.44713251 |
| 115 | T-helper 1 type immune response (GO:0042088) | 2.44287222 |
| 116 | superoxide anion generation (GO:0042554) | 2.44155054 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43967399 |
| 118 | neutrophil activation (GO:0042119) | 2.43854700 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.43554157 |
| 120 | osteoclast differentiation (GO:0030316) | 2.42964570 |
| 121 | negative regulation of interleukin-8 production (GO:0032717) | 2.42307038 |
| 122 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.42304364 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.42028097 |
| 124 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.41765762 |
| 125 | regulation of platelet activation (GO:0010543) | 2.41559987 |
| 126 | urea cycle (GO:0000050) | 2.41539197 |
| 127 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.41450856 |
| 128 | germinal center formation (GO:0002467) | 2.40453117 |
| 129 | regulation of podosome assembly (GO:0071801) | 2.39262932 |
| 130 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.39161103 |
| 131 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.38663116 |
| 132 | surfactant homeostasis (GO:0043129) | 2.38373393 |
| 133 | cellular response to arsenic-containing substance (GO:0071243) | 2.37926266 |
| 134 | glomerular filtration (GO:0003094) | 2.37858666 |
| 135 | granulocyte activation (GO:0036230) | 2.36872752 |
| 136 | positive regulation of cholesterol efflux (GO:0010875) | 2.36337278 |
| 137 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.35771298 |
| 138 | hemidesmosome assembly (GO:0031581) | 2.35739759 |
| 139 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34943000 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34683867 |
| 141 | protein kinase B signaling (GO:0043491) | 2.34431611 |
| 142 | neutrophil chemotaxis (GO:0030593) | 2.34424612 |
| 143 | vitamin transmembrane transport (GO:0035461) | 2.34380778 |
| 144 | positive regulation of vasculogenesis (GO:2001214) | 2.34325192 |
| 145 | sphingolipid catabolic process (GO:0030149) | 2.34198585 |
| 146 | negative regulation of protein autophosphorylation (GO:0031953) | 2.34008588 |
| 147 | prostaglandin metabolic process (GO:0006693) | 2.33948050 |
| 148 | prostanoid metabolic process (GO:0006692) | 2.33948050 |
| 149 | positive regulation of osteoblast proliferation (GO:0033690) | 2.32752313 |
| 150 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.32477520 |
| 151 | cellular response to reactive nitrogen species (GO:1902170) | 2.30660628 |
| 152 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.28709338 |
| 153 | neutrophil migration (GO:1990266) | 2.27704283 |
| 154 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.27542411 |
| 155 | Rap protein signal transduction (GO:0032486) | 2.25238357 |
| 156 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25094671 |
| 157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.24334806 |
| 158 | regulation of macrophage cytokine production (GO:0010935) | 2.22985310 |
| 159 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.22925689 |
| 160 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.21947951 |
| 161 | granulocyte chemotaxis (GO:0071621) | 2.21878653 |
| 162 | barbed-end actin filament capping (GO:0051016) | 2.20978371 |
| 163 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.20803960 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.20714853 |
| 165 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.18819853 |
| 166 | regulation of complement activation (GO:0030449) | 2.18344925 |
| 167 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.18060786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.21149452 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.00875315 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.31079635 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.02879525 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.02879525 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.02879525 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.97340521 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.89689027 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82798248 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.62720169 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.55331949 |
| 12 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.54908294 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54412009 |
| 14 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.48656521 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42498430 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42250331 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.41855600 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36289738 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32393734 |
| 20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32178875 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25319218 |
| 22 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.24321990 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12639504 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09845755 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09075669 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91237323 |
| 27 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.90979549 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.87465541 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.83468437 |
| 30 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.83289465 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.82442803 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80802474 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.80738736 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76324250 |
| 35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.73582533 |
| 36 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72269221 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72102639 |
| 38 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68932449 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68700223 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68047676 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63106190 |
| 42 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62997448 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.60753389 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58787276 |
| 45 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54848517 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.52184311 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.52184311 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51251017 |
| 49 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50701828 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50077354 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49811401 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49780491 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48796643 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47879021 |
| 55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45728489 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44770455 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43663863 |
| 58 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42471711 |
| 59 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42426080 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42024770 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36803891 |
| 62 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.36687484 |
| 63 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36389440 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34797736 |
| 65 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33714866 |
| 66 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33153393 |
| 67 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33153393 |
| 68 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32359093 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31002685 |
| 70 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30304554 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28871682 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28871682 |
| 73 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27936604 |
| 74 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27651356 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23265342 |
| 76 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.22824906 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21663377 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21313385 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20504637 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20079709 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16611455 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16500681 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16108361 |
| 84 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16106798 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15692462 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15543880 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15224978 |
| 88 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11414421 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11389303 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10723674 |
| 91 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.10529794 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09767341 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09380223 |
| 94 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09026764 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09018620 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08642941 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08226095 |
| 98 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07764990 |
| 99 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06879711 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05251370 |
| 101 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02767750 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02690910 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.02277539 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02220129 |
| 105 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01455410 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01176447 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00328342 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00189858 |
| 109 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00139071 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99353307 |
| 111 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99167900 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97220640 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96967156 |
| 114 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96906696 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96488839 |
| 116 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95953129 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94217715 |
| 118 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92616130 |
| 119 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92098706 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90565197 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89344393 |
| 122 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87578927 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87459713 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87388894 |
| 125 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.87258413 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86961674 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86908674 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86250346 |
| 129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86131847 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86025119 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85398266 |
| 132 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82083280 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81696872 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79028929 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78459428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005167_abnormal_blood-brain_barrier | 3.66626646 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.44778166 |
| 3 | MP0003724_increased_susceptibility_to | 3.26660368 |
| 4 | MP0006082_CNS_inflammation | 3.21876208 |
| 5 | MP0001879_abnormal_lymphatic_vessel | 2.95086854 |
| 6 | MP0010368_abnormal_lymphatic_system | 2.72268552 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.59837422 |
| 8 | MP0004883_abnormal_blood_vessel | 2.45852786 |
| 9 | MP0006054_spinal_hemorrhage | 2.38737992 |
| 10 | MP0004272_abnormal_basement_membrane | 2.36024262 |
| 11 | MP0003828_pulmonary_edema | 2.31096241 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.28351972 |
| 13 | MP0003279_aneurysm | 2.18967187 |
| 14 | MP0005164_abnormal_response_to | 2.13082671 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.10154538 |
| 16 | MP0003075_altered_response_to | 2.02408199 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.02097275 |
| 18 | MP0003566_abnormal_cell_adhesion | 1.99814034 |
| 19 | MP0002254_reproductive_system_inflammat | 1.99272516 |
| 20 | MP0003690_abnormal_glial_cell | 1.98808599 |
| 21 | MP0000343_altered_response_to | 1.95117434 |
| 22 | MP0000015_abnormal_ear_pigmentation | 1.92723283 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.91778996 |
| 24 | MP0008260_abnormal_autophagy | 1.89278482 |
| 25 | MP0001851_eye_inflammation | 1.88306372 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.88244876 |
| 27 | MP0002419_abnormal_innate_immunity | 1.87019795 |
| 28 | MP0003436_decreased_susceptibility_to | 1.86413723 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.86407782 |
| 30 | MP0000604_amyloidosis | 1.78431393 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.76124193 |
| 32 | MP0008004_abnormal_stomach_pH | 1.75810215 |
| 33 | MP0002998_abnormal_bone_remodeling | 1.75781606 |
| 34 | MP0005166_decreased_susceptibility_to | 1.75042062 |
| 35 | MP0000767_abnormal_smooth_muscle | 1.73230081 |
| 36 | MP0003303_peritoneal_inflammation | 1.72674131 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.71910784 |
| 38 | MP0001542_abnormal_bone_strength | 1.71048753 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.68746867 |
| 40 | MP0002090_abnormal_vision | 1.64865185 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.57384772 |
| 42 | MP0005083_abnormal_biliary_tract | 1.57136345 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.55668817 |
| 44 | MP0001853_heart_inflammation | 1.55504585 |
| 45 | MP0002009_preneoplasia | 1.52189875 |
| 46 | MP0000685_abnormal_immune_system | 1.51614808 |
| 47 | MP0005409_darkened_coat_color | 1.51516279 |
| 48 | MP0000249_abnormal_blood_vessel | 1.50705348 |
| 49 | MP0005023_abnormal_wound_healing | 1.50309222 |
| 50 | MP0000371_diluted_coat_color | 1.49769466 |
| 51 | MP0009278_abnormal_bone_marrow | 1.46420461 |
| 52 | MP0003448_altered_tumor_morphology | 1.45733411 |
| 53 | MP0003091_abnormal_cell_migration | 1.45258367 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.44938365 |
| 55 | MP0003045_fibrosis | 1.44696146 |
| 56 | MP0005408_hypopigmentation | 1.42146686 |
| 57 | MP0001790_abnormal_immune_system | 1.41666482 |
| 58 | MP0005387_immune_system_phenotype | 1.41666482 |
| 59 | MP0005171_absent_coat_pigmentation | 1.41587078 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.41141071 |
| 61 | MP0001958_emphysema | 1.39245007 |
| 62 | MP0005451_abnormal_body_composition | 1.38273218 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.34757389 |
| 64 | MP0003136_yellow_coat_color | 1.33587837 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.32399270 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.31197254 |
| 67 | MP0005365_abnormal_bile_salt | 1.28882390 |
| 68 | MP0005390_skeleton_phenotype | 1.28313180 |
| 69 | MP0009785_altered_susceptibility_to | 1.27695481 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.27473058 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.26711066 |
| 72 | MP0003329_amyloid_beta_deposits | 1.26652746 |
| 73 | MP0005085_abnormal_gallbladder_physiolo | 1.26457852 |
| 74 | MP0004381_abnormal_hair_follicle | 1.25371449 |
| 75 | MP0005360_urolithiasis | 1.24338687 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.23846401 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.23746398 |
| 78 | MP0005275_abnormal_skin_tensile | 1.21721763 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.20721990 |
| 80 | MP0005165_increased_susceptibility_to | 1.19897631 |
| 81 | MP0004947_skin_inflammation | 1.19225287 |
| 82 | MP0004233_abnormal_muscle_weight | 1.18053189 |
| 83 | MP0001915_intracranial_hemorrhage | 1.16209361 |
| 84 | MP0005503_abnormal_tendon_morphology | 1.14948552 |
| 85 | MP0002933_joint_inflammation | 1.14709069 |
| 86 | MP0000858_altered_metastatic_potential | 1.13677004 |
| 87 | MP0001800_abnormal_humoral_immune | 1.11931180 |
| 88 | MP0009764_decreased_sensitivity_to | 1.11885662 |
| 89 | MP0004484_altered_response_of | 1.09820298 |
| 90 | MP0002166_altered_tumor_susceptibility | 1.06181360 |
| 91 | MP0003941_abnormal_skin_development | 1.04799928 |
| 92 | MP0002405_respiratory_system_inflammati | 1.04464703 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.98883314 |
| 94 | MP0002723_abnormal_immune_serum | 0.98772913 |
| 95 | MP0005508_abnormal_skeleton_morphology | 0.98114198 |
| 96 | MP0003795_abnormal_bone_structure | 0.97989418 |
| 97 | MP0005671_abnormal_response_to | 0.97335129 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.97063445 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.94089359 |
| 100 | MP0009840_abnormal_foam_cell | 0.93217679 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.92740300 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.92415018 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 0.91892733 |
| 104 | MP0000920_abnormal_myelination | 0.91633485 |
| 105 | MP0005025_abnormal_response_to | 0.91596433 |
| 106 | MP0005670_abnormal_white_adipose | 0.91218970 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.90706717 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.89416815 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.89210714 |
| 110 | MP0001614_abnormal_blood_vessel | 0.88358540 |
| 111 | MP0005310_abnormal_salivary_gland | 0.87167866 |
| 112 | MP0002060_abnormal_skin_morphology | 0.87044488 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.85209752 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.84965540 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.84926711 |
| 116 | MP0001819_abnormal_immune_cell | 0.82714771 |
| 117 | MP0002420_abnormal_adaptive_immunity | 0.80316207 |
| 118 | * MP0002136_abnormal_kidney_physiology | 0.79906662 |
| 119 | MP0008469_abnormal_protein_level | 0.79318168 |
| 120 | MP0000733_abnormal_muscle_development | 0.77580782 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.74778258 |
| 122 | MP0002925_abnormal_cardiovascular_devel | 0.74084804 |
| 123 | MP0002115_abnormal_skeleton_extremities | 0.72313612 |
| 124 | MP0001756_abnormal_urination | 0.71240903 |
| 125 | MP0002132_abnormal_respiratory_system | 0.70435869 |
| 126 | MP0009115_abnormal_fat_cell | 0.69674013 |
| 127 | MP0005388_respiratory_system_phenotype | 0.69151687 |
| 128 | MP0002133_abnormal_respiratory_system | 0.69151687 |
| 129 | MP0002075_abnormal_coat/hair_pigmentati | 0.69148534 |
| 130 | MP0005367_renal/urinary_system_phenotyp | 0.66372583 |
| 131 | MP0000516_abnormal_urinary_system | 0.66372583 |
| 132 | MP0001873_stomach_inflammation | 0.66035582 |
| 133 | MP0002796_impaired_skin_barrier | 0.65185984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Axonal loss (HP:0003447) | 4.14529761 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 3.93335893 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.81296778 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.81296778 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.81296778 |
| 6 | Glomerulonephritis (HP:0000099) | 3.74684785 |
| 7 | Hematochezia (HP:0002573) | 3.63049727 |
| 8 | Urethral obstruction (HP:0000796) | 3.61616889 |
| 9 | Arterial tortuosity (HP:0005116) | 3.39799717 |
| 10 | Vascular tortuosity (HP:0004948) | 3.39340305 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.33462696 |
| 12 | White forelock (HP:0002211) | 3.32669422 |
| 13 | Aortic aneurysm (HP:0004942) | 3.31510805 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.22431139 |
| 15 | Epiphyseal dysplasia (HP:0002656) | 3.12619878 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.06352316 |
| 17 | Malnutrition (HP:0004395) | 3.05123519 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.03420798 |
| 19 | Cerebral aneurysm (HP:0004944) | 3.02235918 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.00751755 |
| 21 | Aortic dissection (HP:0002647) | 2.99503379 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99315048 |
| 23 | Mucopolysacchariduria (HP:0008155) | 2.99315048 |
| 24 | Loss of speech (HP:0002371) | 2.97242172 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96652514 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96652514 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96652514 |
| 28 | Thick nail (HP:0001805) | 2.95809673 |
| 29 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.94879249 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.93322786 |
| 31 | Patchy hypopigmentation of hair (HP:0011365) | 2.93257786 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.88094961 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.86286044 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.77646581 |
| 35 | Cupped ribs (HP:0000887) | 2.77557179 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.74163271 |
| 37 | Osteolytic defects of the hand bones (HP:0009699) | 2.71050086 |
| 38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71050086 |
| 39 | Abnormality of the periventricular white matter (HP:0002518) | 2.69679355 |
| 40 | Blue irides (HP:0000635) | 2.65429765 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.55425425 |
| 42 | Prostate neoplasm (HP:0100787) | 2.53452523 |
| 43 | Vertebral compression fractures (HP:0002953) | 2.52286150 |
| 44 | Retinal atrophy (HP:0001105) | 2.48495608 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.47715566 |
| 46 | Alopecia of scalp (HP:0002293) | 2.47050688 |
| 47 | Mutism (HP:0002300) | 2.45251716 |
| 48 | Nephritis (HP:0000123) | 2.41581887 |
| 49 | Absent hand (HP:0004050) | 2.37058256 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.36071586 |
| 51 | Hypoplastic ischia (HP:0003175) | 2.35682511 |
| 52 | Adactyly (HP:0009776) | 2.30060294 |
| 53 | Mitral stenosis (HP:0001718) | 2.28863213 |
| 54 | Ocular albinism (HP:0001107) | 2.28576992 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26037202 |
| 56 | Increased CSF protein (HP:0002922) | 2.23818172 |
| 57 | Cervical subluxation (HP:0003308) | 2.21677580 |
| 58 | Increased connective tissue (HP:0009025) | 2.20055257 |
| 59 | Abnormality of the ischium (HP:0003174) | 2.18994992 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.17192860 |
| 61 | Atrophic scars (HP:0001075) | 2.16494134 |
| 62 | Metaphyseal cupping (HP:0003021) | 2.15354999 |
| 63 | Premature loss of primary teeth (HP:0006323) | 2.15288559 |
| 64 | Vitreoretinal degeneration (HP:0000655) | 2.14687159 |
| 65 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.12368563 |
| 66 | Absent toe (HP:0010760) | 2.09292024 |
| 67 | Muscle fiber splitting (HP:0003555) | 2.08874448 |
| 68 | Progressive visual loss (HP:0000529) | 2.08098679 |
| 69 | Skin nodule (HP:0200036) | 2.06393864 |
| 70 | Xanthomatosis (HP:0000991) | 2.05890641 |
| 71 | Esophageal varix (HP:0002040) | 2.05525073 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.05182493 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.04478169 |
| 74 | Irregular epiphyses (HP:0010582) | 1.99657949 |
| 75 | Gingivitis (HP:0000230) | 1.99103760 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97939669 |
| 77 | Protrusio acetabuli (HP:0003179) | 1.97766619 |
| 78 | Vascular calcification (HP:0004934) | 1.97725278 |
| 79 | Agnosia (HP:0010524) | 1.97251068 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 1.96933064 |
| 81 | Albinism (HP:0001022) | 1.94670758 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93556768 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 1.93540844 |
| 84 | Dysostosis multiplex (HP:0000943) | 1.93287247 |
| 85 | Subacute progressive viral hepatitis (HP:0006572) | 1.92937095 |
| 86 | Myositis (HP:0100614) | 1.92690177 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92666830 |
| 88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91761457 |
| 89 | Epidermoid cyst (HP:0200040) | 1.91071955 |
| 90 | Peripheral demyelination (HP:0011096) | 1.91042692 |
| 91 | Generalized hypopigmentation of hair (HP:0011358) | 1.88731324 |
| 92 | Short hallux (HP:0010109) | 1.88636875 |
| 93 | Amyloidosis (HP:0011034) | 1.88308214 |
| 94 | Small epiphyses (HP:0010585) | 1.87829550 |
| 95 | Myocardial infarction (HP:0001658) | 1.84025567 |
| 96 | J-shaped sella turcica (HP:0002680) | 1.83586615 |
| 97 | Disinhibition (HP:0000734) | 1.83452774 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82741017 |
| 99 | Spondylolisthesis (HP:0003302) | 1.82376273 |
| 100 | Orchitis (HP:0100796) | 1.82330771 |
| 101 | Ileus (HP:0002595) | 1.80905528 |
| 102 | Facial diplegia (HP:0001349) | 1.80380984 |
| 103 | Flat acetabular roof (HP:0003180) | 1.80348470 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 1.80040565 |
| 105 | Impaired platelet aggregation (HP:0003540) | 1.79168001 |
| 106 | Abnormal platelet function (HP:0011869) | 1.79168001 |
| 107 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.77861890 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.77770217 |
| 109 | Ovoid vertebral bodies (HP:0003300) | 1.77709772 |
| 110 | Neoplasm of head and neck (HP:0012288) | 1.76958876 |
| 111 | Esophageal neoplasm (HP:0100751) | 1.76958876 |
| 112 | Complement deficiency (HP:0004431) | 1.76910525 |
| 113 | Recurrent skin infections (HP:0001581) | 1.75539520 |
| 114 | Tetany (HP:0001281) | 1.75263892 |
| 115 | Optic neuritis (HP:0100653) | 1.74638861 |
| 116 | Retrobulbar optic neuritis (HP:0100654) | 1.74638861 |
| 117 | Choroideremia (HP:0001139) | 1.74558307 |
| 118 | Mediastinal lymphadenopathy (HP:0100721) | 1.74462686 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 1.73557508 |
| 120 | Colitis (HP:0002583) | 1.73342779 |
| 121 | Increased serum ferritin (HP:0003281) | 1.72216174 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71996937 |
| 123 | Global brain atrophy (HP:0002283) | 1.71528776 |
| 124 | Scanning speech (HP:0002168) | 1.69965618 |
| 125 | Aplasia involving bones of the extremities (HP:0009825) | 1.69709296 |
| 126 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.69709296 |
| 127 | Aplasia of the phalanges of the hand (HP:0009802) | 1.69709296 |
| 128 | Hypoplasia of the iris (HP:0007676) | 1.68981822 |
| 129 | Abnormal tarsal ossification (HP:0008369) | 1.68960324 |
| 130 | Onion bulb formation (HP:0003383) | 1.68337416 |
| 131 | Stomatitis (HP:0010280) | 1.68021399 |
| 132 | Follicular hyperkeratosis (HP:0007502) | 1.66983765 |
| 133 | Osteomyelitis (HP:0002754) | 1.66982512 |
| 134 | Abnormality of complement system (HP:0005339) | 1.66412863 |
| 135 | Steatorrhea (HP:0002570) | 1.65840433 |
| 136 | Spinal rigidity (HP:0003306) | 1.65801222 |
| 137 | Thin bony cortex (HP:0002753) | 1.63277246 |
| 138 | Iris hypopigmentation (HP:0007730) | 1.62208405 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.61169986 |
| 140 | Elbow flexion contracture (HP:0002987) | 1.60964609 |
| 141 | Absent frontal sinuses (HP:0002688) | 1.60433402 |
| 142 | Camptodactyly of toe (HP:0001836) | 1.59731328 |
| 143 | Joint stiffness (HP:0001387) | 1.59693794 |
| 144 | Abnormality of proline metabolism (HP:0010907) | 1.59350233 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.59350233 |
| 146 | Stomach cancer (HP:0012126) | 1.58855034 |
| 147 | Periodontitis (HP:0000704) | 1.58766942 |
| 148 | Tetraparesis (HP:0002273) | 1.58252250 |
| 149 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.58177364 |
| 150 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.56973409 |
| 151 | Hypoplasia of the odontoid process (HP:0003311) | 1.56858078 |
| 152 | Upper limb muscle weakness (HP:0003484) | 1.55861928 |
| 153 | Abnormality of the nasal septum (HP:0000419) | 1.54228178 |
| 154 | Platyspondyly (HP:0000926) | 1.54041231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.37150471 |
| 2 | TIE1 | 4.14135399 |
| 3 | AKT3 | 3.58940305 |
| 4 | BLK | 2.83813393 |
| 5 | KDR | 2.79813366 |
| 6 | EPHA2 | 2.72871646 |
| 7 | ERN1 | 2.69473031 |
| 8 | MAP3K14 | 2.69306638 |
| 9 | MAP3K3 | 2.63350517 |
| 10 | PRPF4B | 2.37518941 |
| 11 | NEK9 | 2.26732600 |
| 12 | TBK1 | 2.22330925 |
| 13 | ACVR1B | 2.15972151 |
| 14 | MAPK15 | 2.07171313 |
| 15 | FER | 1.98993685 |
| 16 | IRAK3 | 1.76157578 |
| 17 | RIPK4 | 1.74825683 |
| 18 | MAP2K2 | 1.73572338 |
| 19 | MST4 | 1.72615866 |
| 20 | ZAP70 | 1.71356025 |
| 21 | STK10 | 1.64244860 |
| 22 | TSSK6 | 1.56590396 |
| 23 | IKBKB | 1.54680225 |
| 24 | FRK | 1.53311847 |
| 25 | PBK | 1.48289342 |
| 26 | GRK7 | 1.41001629 |
| 27 | IRAK4 | 1.36283440 |
| 28 | MAP3K13 | 1.35674356 |
| 29 | IKBKE | 1.34644873 |
| 30 | MAP3K2 | 1.34472822 |
| 31 | PRKG2 | 1.33920166 |
| 32 | CSK | 1.31840080 |
| 33 | ICK | 1.27959316 |
| 34 | TTN | 1.27732410 |
| 35 | PAK4 | 1.26860714 |
| 36 | TGFBR1 | 1.26476703 |
| 37 | TRPM7 | 1.26174714 |
| 38 | STK39 | 1.26167525 |
| 39 | PAK2 | 1.18096681 |
| 40 | MAP3K1 | 1.15280034 |
| 41 | TYK2 | 1.14706380 |
| 42 | OXSR1 | 1.13399868 |
| 43 | PIK3CA | 1.13352151 |
| 44 | MST1R | 1.11180998 |
| 45 | DDR2 | 1.10225974 |
| 46 | GRK1 | 1.08839206 |
| 47 | TAOK2 | 1.05993032 |
| 48 | EPHB1 | 1.04861193 |
| 49 | IRAK1 | 1.04539587 |
| 50 | LATS1 | 1.02458648 |
| 51 | TXK | 1.01353085 |
| 52 | MET | 1.00815579 |
| 53 | MYLK | 0.99962685 |
| 54 | JAK1 | 0.99154050 |
| 55 | CDC42BPA | 0.98809298 |
| 56 | MATK | 0.97981746 |
| 57 | RPS6KA4 | 0.95540245 |
| 58 | MOS | 0.93931350 |
| 59 | EPHB2 | 0.93040891 |
| 60 | MAP2K3 | 0.92037094 |
| 61 | FGFR3 | 0.90949046 |
| 62 | BMX | 0.90564575 |
| 63 | PIM2 | 0.89685231 |
| 64 | RIPK1 | 0.87956948 |
| 65 | GSK3A | 0.87550037 |
| 66 | MAPKAPK3 | 0.86388620 |
| 67 | PTK6 | 0.85756669 |
| 68 | * PDPK1 | 0.84474404 |
| 69 | PIK3CG | 0.83116236 |
| 70 | CSF1R | 0.82541116 |
| 71 | FGFR4 | 0.79008016 |
| 72 | * MAPK7 | 0.78757163 |
| 73 | PDGFRB | 0.77744002 |
| 74 | EPHA3 | 0.75051403 |
| 75 | MAPK4 | 0.74711126 |
| 76 | INSR | 0.74617316 |
| 77 | PRKAA2 | 0.72476178 |
| 78 | IRAK2 | 0.72164532 |
| 79 | IGF1R | 0.71006889 |
| 80 | MAP4K1 | 0.70630691 |
| 81 | MELK | 0.69915212 |
| 82 | KSR2 | 0.69576523 |
| 83 | FES | 0.64452272 |
| 84 | MAPK11 | 0.64450671 |
| 85 | CHUK | 0.63726128 |
| 86 | MARK3 | 0.62838561 |
| 87 | PRKD1 | 0.62598348 |
| 88 | RPS6KA2 | 0.62345241 |
| 89 | CDK6 | 0.62220090 |
| 90 | MAP2K1 | 0.61850500 |
| 91 | MAP3K7 | 0.61324866 |
| 92 | CAMKK2 | 0.61223745 |
| 93 | PTK2B | 0.60547556 |
| 94 | CDK12 | 0.59677124 |
| 95 | HCK | 0.59598699 |
| 96 | SGK3 | 0.57927523 |
| 97 | EGFR | 0.57558237 |
| 98 | ERBB4 | 0.56823437 |
| 99 | * MTOR | 0.56530694 |
| 100 | MAPKAPK5 | 0.55195431 |
| 101 | ITK | 0.54954899 |
| 102 | JAK2 | 0.54906707 |
| 103 | MAP3K6 | 0.53055826 |
| 104 | TRIB3 | 0.52770160 |
| 105 | PRKD2 | 0.52711921 |
| 106 | * PDK2 | 0.52676016 |
| 107 | STK38 | 0.51925984 |
| 108 | PIM1 | 0.51900185 |
| 109 | RAF1 | 0.51333159 |
| 110 | * PDK1 | 0.51031603 |
| 111 | STK3 | 0.50992359 |
| 112 | CAMK1D | 0.50677553 |
| 113 | LMTK2 | 0.50469727 |
| 114 | BMPR2 | 0.49107734 |
| 115 | SYK | 0.49035008 |
| 116 | MAPKAPK2 | 0.47649854 |
| 117 | PDGFRA | 0.47405863 |
| 118 | BMPR1B | 0.46832529 |
| 119 | KIT | 0.46660192 |
| 120 | JAK3 | 0.45418539 |
| 121 | EIF2AK2 | 0.44690874 |
| 122 | ABL1 | 0.44277349 |
| 123 | ERBB3 | 0.42718930 |
| 124 | LATS2 | 0.41293595 |
| 125 | FGR | 0.40362288 |
| 126 | LCK | 0.38742359 |
| 127 | NLK | 0.37060423 |
| 128 | INSRR | 0.36840348 |
| 129 | PRKCD | 0.35867811 |
| 130 | PTK2 | 0.35411025 |
| 131 | * MAPK12 | 0.35359793 |
| 132 | PRKCH | 0.34802024 |
| 133 | ERBB2 | 0.32214253 |
| 134 | ABL2 | 0.31902216 |
| 135 | LYN | 0.31605759 |
| 136 | NUAK1 | 0.28656277 |
| 137 | BCKDK | 0.28162859 |
| 138 | PKN1 | 0.27409328 |
| 139 | PRKCE | 0.26223847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.69429682 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.86216554 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.69167216 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59861435 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17057817 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.16136319 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05979877 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02589284 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.96899735 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.88404191 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.86891727 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.83330124 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.79856358 |
| 14 | Adherens junction_Homo sapiens_hsa04520 | 1.67703697 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.65276866 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63761482 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54927417 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.53734780 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51892075 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49717663 |
| 21 | Mineral absorption_Homo sapiens_hsa04978 | 1.46099289 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46077472 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.43630750 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41274206 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.41193473 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36784390 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.35997835 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.35287587 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33135666 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25959477 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.24059743 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.19809700 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15774011 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14493364 |
| 35 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.14374393 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.13506261 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.13376017 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11409778 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11383994 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10870399 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09443586 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07533633 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02598045 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01758050 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00258907 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98109208 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.96861222 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94639275 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93898701 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92565014 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.90658463 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.89315380 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87627447 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87339418 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86773240 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.85359963 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85216331 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85128176 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84464396 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83814336 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83789501 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.83242313 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82159895 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81953570 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81859984 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81190204 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80787079 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80194572 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79940173 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79526241 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79514471 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.77941808 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.77531142 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77125330 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75668393 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.73118559 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.72315479 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71803481 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71153784 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71112190 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70597708 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70456324 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70385981 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.70143031 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68299124 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.68037990 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67638437 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66180843 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.66104193 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65596207 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65453451 |
| 92 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64668937 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.63352529 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63311822 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62487786 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61456585 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61254339 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60123613 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60009650 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.59779496 |
| 101 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59047404 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.58892069 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58506714 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58497202 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57680998 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56516050 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56158233 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54573547 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53909921 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52408972 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52054776 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51345326 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50085590 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50014088 |
| 115 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48970674 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47994097 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47170631 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46770935 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44517410 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44429821 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43951953 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43682397 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40420645 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40315928 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40260000 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40057713 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38574935 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38573808 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37129734 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37050140 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36392633 |

